Recurrent Non-small Cell Lung Cancer Completed Phase 1 Trials for Gemcitabine (DB00441)

Also known as: Non-Small Cell Lung Cancer Recurrent / Lung cancer non-small cell recurrent

IndicationStatusPhase
DBCOND0028805 (Recurrent Non-small Cell Lung Cancer)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00052338Bortezomib Plus Gemcitabine and Carboplatin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung CancerTreatment
NCT00066768Suramin and Either Docetaxel or Gemcitabine in Treating Patients With Stage IIIB or Stage IV Platinum-Refractory Non-Small Cell Lung CancerTreatment